SCHEMBL7552973

SCHEMBL7552973

O=C1NNC(=O)C1=CNc1ccc(F)cc1F

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.45
MEN1 O00255 3/20 0.45
ALDH1A1 P00352 6/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MAPT P10636 3/20 0.39
PKM P14618 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 2/20 0.38
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
AKT1 P31749 1/20 0.36
EGFR P00533 1/20 0.36
KDM4E B2RXH2 1/20 0.36
SOS1 Q07889 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11887923 0.77 KDR (0.53) KMT2AMEN1ALDH1A1SMN1; SMN2NPC1
SCHEMBL7545623 0.74 KMT2A (0.39) KMT2AMEN1ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL988638 0.72 ALDH1A1 (0.47) KMT2AMEN1ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL10466153 0.69 LMNA (0.44) KMT2AMEN1ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL7554269 0.66 KMT2A (0.45) KMT2AMEN1ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL7554267 0.66 KMT2A (0.45) KMT2AMEN1ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL10703851 0.64 ALDH1A1 (0.64) KMT2AMEN1ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL182042 0.61 CA1 (0.53) KMT2AMEN1ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL18500606 0.61 HTT (0.46) KMT2AMEN1ALDH1A1CYP2C19SMN1; SMN2
SCHEMBL4658586 0.61 HTT (0.46) KMT2AMEN1ALDH1A1CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020058244-A1 Method for detecting uracil biosynthesis inhibitors and their use as herbicides BASF AKTIENGESELLSCHAFT (DE) 2002-05-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020058244-A1 Method for detecting uracil biosynthesis inhibitors and their use as herbicides UMPS, UGP2, UNG KMT2A 2193/4885MEN1 4364/4885ALDH1A1 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.